Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2011

View Archived Issues

ArQule and Daiichi Sankyo disclose preclinical findings on ARQ-092

New biomarker for dengue fever identified

Acasti Pharma begins second phase II CaPre study

New serine/threonine-protein kinase ATR inhibitors claimed

Second remissions evaluated in epratuzumab study in relapsed acute lymphoblastic leukemia

Paladin Labs launches product for digoxin toxicity and overdose in Canada

New glimepiride formulation launched in Japan

Neoprobe licenses imaging agent from AstraZeneca

Antitumor effects of K-560 evaluated in preclinical settings

Novel antimalarial is potent without inducing parasite dormancy

Researchers at Chemilia design new anticancer agents

New histamine H3 receptor modulators presented

Novel antibacterial and antifungal agents disclosed by A*STAR

Baxter International signs acquisition agreement

Tarsa Therapeutics plans NDA submission for oral recombinant calcitonin

FDA committee issues vote on Adasuve

Japanese phase II/III trial in osteoporosis meets primary endpoint

Simcere and Bristol-Myers Squibb extend partnership

OSI Pharmaceuticals presents new macrophage-stimulating protein receptor inhibitors

Pharmalink in-licenses Archimedes Pharma technology

Treatment begins in pivotal phase III CXA-201 trial

Avila Therapeutics product shows promise to treat hematological cancers

Bayer HealthCare submits applications for long-term contraceptive system

ATx08-001 study meets primary objectives

Zybrestat to be provided on a compassionate-use basis

Veregen mutual recognition approval process continues

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...